Bioverativ Therapeutics Inc.
0 sources
Summary
Bioverativ Therapeutics Inc. is a business[1].
Key Facts
- Bioverativ Therapeutics Inc. is in the country of US[2].
- Bioverativ Therapeutics Inc.'s instance of is recorded as business[3].
- Bioverativ Therapeutics Inc.'s parent organization or unit is recorded as Bioverativ[4].
- Bioverativ Therapeutics Inc.'s parent organization or unit is recorded as gleif:549300E9PC51EN656011[5].
- Bioverativ Therapeutics Inc.'s legal form is recorded as ZJTK[6].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 549300FG1M08D5DJ1X84[7]
-
Registered legal name: Bioverativ Therapeutics Inc.[8]
-
Legal jurisdiction: US-MA[9]
-
GLEIF entity category: GENERAL[10]
-
Legal form (ISO 20275 ELF): ZJTK[11]
-
Entity status: ACTIVE[12]
-
LEI registration status: LAPSED[13]
-
LEI first registered: 2018-06-05[14]
-
LEI last updated: 2023-08-04[15]
-
LEI next renewal: 2019-06-04[16]
-
Managing LOU: 5493001KJTIIGC8Y1R12[17]
-
Registration authority: RA000613[18]
-
Authority entity ID: 133957867[19]
-
Other names: Syntonix Pharmaceuticals[20]
-
Conformity flag: NON_CONFORMING[21]
Body
Operations
Parent organizations include Bioverativ[4], a public company[22], in United States[23], founded in 2016[24], headquartered in Waltham[25] and gleif:549300E9PC51EN656011[5].